Pediatrix Medical Group, Inc.
MD
$19.70
-$0.19-0.96%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.91B | 1.92B | 1.94B | 1.98B | 2.01B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.91B | 1.92B | 1.94B | 1.98B | 2.01B |
| Cost of Revenue | 1.42B | 1.43B | 1.47B | 1.51B | 1.56B |
| Gross Profit | 493.70M | 496.25M | 472.72M | 462.11M | 454.34M |
| SG&A Expenses | 240.79M | 238.66M | 235.99M | 236.84M | 238.44M |
| Depreciation & Amortization | 21.83M | 23.07M | 23.77M | 27.25M | 32.23M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.68B | 1.69B | 1.73B | 1.78B | 1.83B |
| Operating Income | 231.09M | 234.51M | 212.95M | 198.02M | 183.68M |
| Income Before Tax | 216.43M | 204.17M | 141.62M | -81.08M | -101.34M |
| Income Tax Expenses | 51.04M | 41.98M | 31.70M | 1.29M | -2.27M |
| Earnings from Continuing Operations | 165.39 | 162.19 | 109.92 | -82.37 | -99.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 165.39M | 162.19M | 109.92M | -82.37M | -99.07M |
| EBIT | 231.09M | 234.51M | 212.95M | 198.02M | 183.68M |
| EBITDA | 252.91M | 257.58M | 236.73M | 225.27M | 215.91M |
| EPS Basic | 1.96 | 1.91 | 1.30 | -1.00 | -1.20 |
| Normalized Basic EPS | 1.61 | 1.61 | 1.40 | 1.26 | 1.12 |
| EPS Diluted | 1.94 | 1.90 | 1.29 | -1.01 | -1.20 |
| Normalized Diluted EPS | 1.60 | 1.60 | 1.39 | 1.25 | 1.12 |
| Average Basic Shares Outstanding | 338.26M | 339.00M | 338.28M | 336.82M | 335.25M |
| Average Diluted Shares Outstanding | 340.99M | 341.73M | 340.64M | 338.45M | 336.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |